Skip to Main Content

Go to Main Navigation

Cytes Biotechnologies

Year Established:
Barcelona, Barcelona, ES
Company Type:
Small Business (1-10M TTM Revenue)

Cytes Biotechnologies is a biotechnological company that offers products and services (CRO) based on tissue procurement, cell isolation, and cell solutions for in vitro models addressed to the research community worldwide.

The company’s main focus is the isolation and full characterization of primary human and animal hepatic and skin cells, as well as providing different tissue explants (pathological and healthy donors).

Cytes Biotechnologies offers an extensive portfolio of fresh and cryopreserved human and animal cells.
Among others, plateable and suspension hepatocytes, stellates, Kupffers, hepatic endothelial, liver sinusoidal endothelial cells, liver subcellular fractions, skin fibroblasts, and keratinocytes.

Some of Cytes competitive advantages are:

• Access to unlimited healthy and pathological human tissue
• High expertise in cell isolation and cryopreservation with proprietary protocols
• End-to-end control of the whole isolation process, from organ procurement to cell distribution
• Production of Human hepatocytes and NPCs from the same donor
• Extensive donor medical information
• Adapted Liver Cells Conditions and CRO services
• Logistic expertise to distribute fresh and cryopreserved cells
• Laboratory with GMP conditions under requirement

Site Badges
F. Hoffmann-La Roche Ltd.
Grenzacherstrasse 124 Switzerland, Basel , 4070 Spain
Cytes Biotechnologies SL
C/Baldiri Reixac 4-8, torre I Barcelona, Barcelona, 08028 Spain
Cytes Biotechnologies SL
Av. San Juan Bosco 13 Zaragoza, Zaragoza, 50009 Spain

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service